Bio

Harvard trained MD, ex-McKinsey biotech CEO / CMO, entrepreneur (co-founder and CEO of Exacis Biotherapeutics and former CEO of Sollis Therapeutics; founder at Fiore Healthcare & SSI Strategy), and angel investor (healthcare, media, consumer products, biotech, travel tech). Business Leadership and Business Development: Board Member at Eterna Therapeutics and Exacis Biotherapeutics and the Advanced Group of Companies, former Board Member of Sollis Therapeutics. Founder and CEO at Exacis Biotherapeutics, founder and former CEO of Sollis Therapeutics, former management consultant (McKinsey and Company) and founder of two pharmaceutical consultancies (Fiore Healthcare Advisors and SSI Strategy) that have been acquired. Clinical Research: Former CMO of The Medicines Company as well as consulting CMO at several development and commercial stage biopharma companies; experience in CV/Renal, intensive care medicine, rare diseases [cystic fibrosis], analgesia, anti-infective, research governance and policy. Drug Safety/PV: Head of Safety or external head for more than 10 companies; safety governance, PV system and QMS design; many successful health authority inspections and responses; global safety database owner; extensive outsourcing/offshoring experience with focus on quality.